Genetically encoded magnetic resonance imaging (MRI) contrast agents enable non-invasive detection of specific biomarkers in vivo. Here, we employed the hyper-CEST 
Introduction
The development of molecular probes for quantifying the in vivo distribution of biologically active species (e.g., metabolites, neurotransmitters) is critical to understanding both normal physiology and disease pathologies. Magnetic resonance imaging (MRI) offers excellent spatiotemporal resolution and penetration depth without the use of ionizing radiation. Functional MRI (fMRI) has spurred the development of "smart" contrast agents that are responsive to specic physiological triggers 1 such as metal ions, 2 metabolites, 3 and enzymes. 4 Genetically encoded (GE) contrast agents can be expressed directly in the tissue of interest and tailored to bind specic analytes through biomolecular engineering techniques such as directed evolution.
5,6
In pioneering work, Shapiro and coworkers evolved bacterial cytochrome P450-BM3 to bind dopamine near the paramagnetic heme, which was designed to decrease 1 H MRI signal: 89 mM BM3 enabled detection of 75 mM dopamine in live rat brain. 6 An alternative contrast approach is 1 H chemical exchange saturation transfer ( 1 H-CEST), which uses selective radiation to depolarize solute-bound protons, then measures loss of bulk solvent proton signal as protons exchange from solute to solvent (i.e., magnetization transfer).
7
By this method, Oskolkov and coworkers observed MR contrast from 733 mM human protamine-1, an arginine-rich nuclear protein that was sensitive to pH, phosphorylation state, nucleotides, and heparin. 8 Notably, the low sensitivity of 1 H MRI has limited the development of GE T 1 , T 2 , and 1 H-CEST contrast agents for molecular imaging.
9
Nuclear hyperpolarization provides a unique strategy to overcome natural limitations in NMR sensitivity.
10,11
For example, the spin- Xe can be hyperpolarized (hp) through spin-exchange optical pumping (SEOP) to increase net magnetization by several orders of magnitude.
12,13 Synthetic xenon biosensors 14 have been developed by targeting a cryptophane-A or curburbit [6] uril host to report on proteins, [15] [16] [17] [18] glycans, 19 39 and electrochemical response. 40 Moreover, MBP has been engineered to increase ligand affinity 41, 42 and to bind non-maltodextrin ligands such as sucrose 43 and zinc.
44
Thus, we set out to evaluate the hyper-CEST NMR contrast generated by MBP as a function of maltose binding.
Results and discussion

Maltose detection by MBP
Xenon hyper-CEST z-spectra were acquired from recombinant MBP in both the presence and absence of maltose to assess the magnitude and frequency of NMR saturation contrast (Fig. 2a) . (Table S1 †) .
To assess the detection sensitivity of MBP, time-dependent saturation transfer experiments were performed by measuring Xe (aq) polarization as a function of saturation time (Fig. S2 †) . Saturation frequencies of d-SNOB pulses were positioned +95 ppm and À95 ppm, referenced to the Xe (aq) peak, for onand off-resonance, respectively. The normalized difference between on-and off-resonance saturation transfer was measured as on-resonance hyper-CEST contrast. By this method, 100 nM MBP with 1 mM maltose reported 0.26 AE 0.01 saturation contrast; by comparison, 0.23 AE 0.02 saturation contrast was observed for 100 nM Bla. 31 To evaluate the responsiveness of MBP MR contrast to maltose, additional saturation contrast measurements were taken for 100 nM MBP with decreasing maltose. The lowest maltose concentration that could be readily detected by MBP was 100 nM, with an observed saturation contrast of 0.050 AE 0.007. For each maltose concentration, the amount of MBP closed (i.e., contrast "ON") was calculated using a K d of 1 mM. The observed saturation contrast was linearly proportional (R 2 ¼ 0.953) to the percentage of MBP in the maltose-bound closed conformation, which provides a measure of maltose concentration (Fig. 2b ).
Mutagenesis to modulate maltose detection sensitivity
To extend the detection threshold of MBP, Ile-329 was mutated to Tyr to greatly increase maltose affinity (K d
41,42 Importantly, Ile-329 is located in a "hinge region" opposite the maltose-binding cle, far enough away from the Xe-binding site to reasonably assume that mutations at this position should not affect Xe exchange. The I329Y mutation was introduced to a MBP-GFP fusion construct prepared to facilitate protein quantitation during cell studies (vide infra). The Xe hyper-CEST z-spectrum of MBP(I329Y)-GFP in the presence of 1 mM maltose is comparable to WT MBP (Fig. S3 †) , though the saturation response of Xe@MBP(I329Y)-GFP is shied 5 ppm downeld and is slightly attenuated compared to WT. Saturation contrast measurements for 100 nM MBP(I329Y)-GFP followed the same procedure used for WT MBP, but with the saturation frequencies of d-SNOB pulses positioned +100 ppm and À100 ppm (Fig. S4 †) . As observed for WT MBP, saturation contrast was linearly proportional (R 2 ¼ 0.997) to the percentage of MBP in the maltose-bound closed conformation (Fig. 2b) . The detection threshold for the I329Y mutant was 32 nM maltose, which gave rise to saturation contrast of 0.07 AE 0.01.
These saturation contrast data demonstrate that MBP can be "tuned" through mutagenesis to detect maltose across varying concentration ranges. High-affinity mutants such as I329Y can be employed for nM-to-low mM maltose detection, whereas WT MBP can be used for low mM-to-mM maltose detection.
Hyper-CEST of MBP in E. coli
To evaluate the hyper-CEST contrast detectable from MBP in a cellular environment, MBP with a C-terminal GFP tag (MBP-GFP) was expressed in BL21 (DE3) E. coli cells and timedependent saturation transfer measurements were taken following the same protocol used for puried WT MBP (Fig. S5 †) . Using the GFP tag, MBP concentration was quantied in real-time by uorescence intensity at 510 nm (l ex ¼ 489 nm). E. coli growths not induced with IPTG served as controls to measure background contrast. Cells were washed with PBS and then transferred to an NMR tube for data collection. Control E. coli reported saturation contrasts of 0.11 AE 0.01 and 0.09 AE 0.01 with and without 1 mM maltose, respectively. Background contrast at 95 ppm downeld from Xe (aq) likely arises from Xe exchanging with the hydrophobic interior of cellular membranes. E. coli expressing MBP in the presence of maltose reported 0.25 AE 0.02 saturation contrast (Table 1) , nearly ve-fold higher than E. coli expressing MBP in the absence of maltose (0.14 AE 0.01), aer subtraction of background (0.11 AE 0.01) from both. This highlights a mechanism for designing xenon-based MRI molecular imaging agents capable of detecting a specic analyte in cellular milieu.
Multiplexed MR contrast
The saturation frequency of Xe@MBP is sufficiently downeld of Xe@Bla that we hypothesized that the two proteins could be detected sequentially and very sensitively with minimal crosstalk using hyper-CEST in the same solution. The hyper-CEST zspectrum of a mixture of MBP and Bla was acquired, where the ratio of MBP to Bla was lowered to approximately equalize the magnitude of contrast produced by the two proteins (Fig. 3) . The z-spectrum of 27 mM MBP and 80 mM Bla in the absence of maltose showed two peaks: Xe (aq) at 0 ppm, and Xe@Bla at 60 ppm. In the presence of 1 mM maltose, three peaks were observed: Xe (aq) at 0 ppm, Xe@Bla at 60 ppm, and Xe@MBP at 95 ppm. Critically, the magnitude of saturation contrast at 60 ppm for Xe@Bla was not affected by maltose or whether MBP contrast was "on" or "off". We envision that the ability to multiplex the responsive hyper-CEST agent, MBP, with a nonresponsive hyper-CEST agent such as Bla, should enable the in vivo quantitation of maltose via ratiometric analysis. Indeed, ratiometric approaches employing uorescent small molecules and proteins have been widely applied for detection of ions and biomolecules in solution and in cellular studies. 
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CEST contrast dependence on MBP conformation
To ascertain whether hyper-CEST contrast with MBP results from the closed conformation induced by maltose binding or from sugar binding alone, the z-spectrum of MBP in the presence of b-cyclodextrin (bCD) was obtained (Fig. S6 †) . bCD binds MBP with good affinity (K d ¼ 1.8 mM) in the same cle as maltose, but its larger size prevents MBP from adopting a closed conformation. 46 The z-spectrum of MBP with bCD shows no downeld saturation response, indicating that the maltosebound closed conformation is required for producing hyper-CEST contrast. The lack of saturation contrast with MBP + bCD was unexpected given that Xe has higher affinity for MBP + bCD than MBP + maltose. Previous nances. 33 Indeed, the fact that the Xe (aq) peak is broadened more by bCD (FWHM ¼ 60 ppm) than by maltose (47 ppm) reveals a greater degree of Xe exchange with MBP + bCD than MBP + maltose (Table S1 †). The structural basis for a difference in Xe affinity is not obvious, however, as the contours of the Xebinding cavity are largely conserved among several MBP complexes (Fig. S7 †) . It therefore appears that the primary determinant of hyper-CEST contrast in MBP is rate of Xe exchange, not Xe affinity. Xe exchange is likely too fast ($MHz frequency) with MBP open (with or without bCD), but the binding of maltose and the conformational change to MBP closed slows the rate of Xe exchange to resolve a separate peak in the zspectrum.
Mutagenesis to identify origin of hyper-CEST contrast
We performed mutagenesis experiments to further probe the mechanism of Xe CEST with MBP. Val-293 was chosen as the site for single-point mutations due to its proximity to bound Xe identied in the maltose-free MBP structure (Fig. 1) . The methyl carbons of Val-293 are only 4.0 and 4.2Å from Xe, respectively, thus it was expected that mutations at this position would affect Xe binding affinity and/or kinetics. Val-293 was mutated to Leu to reduce the cavity volume, and to Ala to enlarge the cavity. CD and uorescence spectroscopy, along with thermal stability assays, conrmed that the V293L and V293A mutants retained the same global structure and maltose-binding properties as WT MBP (Fig. S8 and S9 , Table S2 †) .
Hyper-CEST z-spectra of V293L and V293A were obtained following the same protocol used for WT MBP (Fig. S10 †) (Fig. S11 †) . The molecular features of this signal enhancement and chemical shi change are under investigation.
Conclusions
In summary, we have demonstrated that 100 nM MBP generates signicant saturation contrast in vitro and that observed contrast is proportional to % MBP closed , thereby characterizing MBP as a "smart" analyte-sensitive biosensor. The I329Y MBP sensor at 100 nM concentration detected maltose in the range 32 nM to 5 mM, whereas 100 nM WT MBP detected maltose in the range 100 nM to 1 mM. Notably, the large (+95 ppm) 129 Xe NMR chemical shi was generated within the GE MBP molecule and did not require post-translational modication or cofactor such as a lanthanide or other paramagnetic shi agent. Additionally, WT MBP appended with GFP was readily detected at 1 mM via hyper-CEST NMR when expressed in E. coli. by withholding maltose until Xe-MBP signal was desired. Experiments with I329Y MBP conrm 3-4 orders-of-magnitude higher small-molecule sensitivity than that achieved with available GE T 1 or 1 H-CEST contrast agents. Indeed, nM maltose detection via MBP hyper-CEST NMR rivals the small-molecule detection sensitivity of many GE uorescent sensors. The increased contrast generated by V293A (and loss of contrast observed for V293L) conrms that MBP-CEST efficiency can be enhanced with mutations to the xenon binding site: coupling this with mutations promoting the maltosebound, MBP-closed conformation 41, 42 should yield a superior biosensor. Furthermore, the modulated saturation frequency of V293A (d ¼ 36 ppm, shied 59 ppm upeld from WT MBP) suggests that rational mutagenesis will yield MBP variants with a broad range of 129 Xe NMR chemical shis, akin to the palette of uorescent proteins such as GFP and mCherry commonly used for multiplexed cellular imaging. 50 Similar attempts to engineer Bla through site-directed mutagenesis have so far failed to improve or modulate its CEST signal (unpublished data), which makes MBP a particularly versatile protein system for elucidating the hyper-CEST mechanism. Finally, MBP variants that have been engineered previously to bind different ligands 43, 44 highlight the exciting potential for employing MBPenhanced 129 Xe NMR/MRI to detect bioactive molecules present in mammalian cells.
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